FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.

Hospira, Inc. confirmed the FDA's approval of its ANDA for LidoCaine Hydrochloride and Epinephrine intended for epidural administration, a product launch that is expected to expand the manufacturer's footprint in the anesthesiology market and offer a competitive alternative to branded offerings.